Lauren Cook
Women's Health · North Chesterfield, VANPI 1861959033
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,160 of the $1,375 with a category attached, or 84.3%. 20 manufacturers reported payments, led by Medtronic at 32.7% of the total. Reporting peaked in 2023 at $494 and has fallen 74.7% since, to $125 in 2025.
Across 62 payments — averaging $22.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$450
- Exeltis, USA Inc.$121
- AbbVie$101
- Novo Nordisk$94
- Pfizer$85
- Biogen$85
- plus $439 from 14 others
What the payments were for
- Travel & lodging$15111%
- Food & beverage$1,16084%
- Education$645%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 6 | $450 |
| Exeltis, USA Inc. | 8 | $121 |
| AbbVie | 6 | $101 |
| Novo Nordisk | 7 | $94 |
| Pfizer | 5 | $85 |
| Biogen | 5 | $85 |
| Therapeuticsmd, Inc. | 4 | $61 |
| Millicent US Inc | 2 | $61 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| Astellas Pharma US Inc | 3 | $49 |
| Myovant Sciences Inc. | 3 | $44 |
| Amgen | 2 | $26 |
| Lilly USA, LLC | 1 | $25 |
| Organon | 1 | $23 |
| Lupin Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $17 |
| Mayne Pharma Commercial LLC | 1 | $16 |
| Bayer | 1 | $12 |
| Agile Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$250
How this compares
$1,375 in reported general payments places this provider in the 80th percentile of 188 women's health providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 25 | $15,723 |
| Estradiol | 97 | $6,487 |
| Clindamycin Phosphate | 43 | $2,475 |
| Trimethoprim | 23 | $1,813 |
| ValacyclovirValacyclovir Hcl | 31 | $1,391 |
| NitrofurantoinNitrofurantoin Macrocrystal | 42 | $1,344 |
| Norethin-Eth Estra-Ferrous FumNoreth-Ethinyl Estradiol/Iron | 18 | $1,248 |
| Solifenacin Succinate | 13 | $642 |
| Clobetasol Propionate | 21 | $575 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 26 | $313 |
| Cephalexin | 27 | $187 |
| Amitriptyline Hcl | 14 | $141 |
| Fluconazole | 21 | $101 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $87 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $56 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $49 | $15,72325 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 188 women's health providers in Virginia.
Other women's health in North Chesterfield
- Heather PayneCharlottesville$28K
- Heather HallbergVirginia Beach$27K
- Whitney CottonVirginia Beach$14K
- Kara ParkerRichmond$10K
- Jenifer CotterVirginia Beach$6K
- Jessica JohnsonHampton$3K
- Elizabeth LambRichmond$3K
- Yvonne PierceAlexandria$3K
- Virginia WeiszRoanoke$3K
- Christine KlamLeesburg$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.